Sectra AB (MIL:1SECT) PE Ratio without NRI: 101.78 (As of Jun. 27, 2026) — 25% Above Median


MIL:1SECT Sectra AB MIL:1SECT
78 GF Score
Price €27.38
GF Value €28.93
Valuation Fairly Valued
View Full Analysis

What is Sectra AB PE Ratio without NRI?

Sectra AB MIL:1SECT 78 PE Ratio without NRI is 101.78 as of Jun. 27, 2026, which is 25% above its 10-year median of 81.33. GuruFocus rates MIL:1SECT with a GF Score™ of 78/100 and a GF Value™ of €28.93 (Fairly Valued). Among 448 Medical Devices & Instruments companies, Sectra AB ranks worse than 90.63% on this metric.

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2026-06-27), Sectra AB's share price is €27.38. Sectra AB's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27. Therefore, Sectra AB's PE Ratio without NRI for today is 101.78.

During the past 13 years, Sectra AB's highest PE Ratio without NRI was 146.93. The lowest was 34.87. And the median was 81.33.

Sectra AB's EPS without NRI for the three months ended in Apr. 2026 was €0.08. Its EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27.

As of today (2026-06-27), Sectra AB's share price is €27.38. Sectra AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27. Therefore, Sectra AB's PE Ratio (TTM) for today is 101.78.

During the past years, Sectra AB's highest PE Ratio (TTM) was 146.93. The lowest was 34.78. And the median was 81.33.

Sectra AB's EPS (Diluted) for the three months ended in Apr. 2026 was €0.08. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27.

Sectra AB's EPS (Basic) for the three months ended in Apr. 2026 was €0.08. Its EPS (Basic) for the trailing twelve months (TTM) ended in Apr. 2026 was €0.27.


Sectra AB  (MIL:1SECT) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Sectra AB PE Ratio without NRI Related Terms


Sectra AB PE Ratio without NRI Historical Data

* Premium members only.

The historical data trend for Sectra AB's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sectra AB PE Ratio without NRI Chart

Sectra AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
PE Ratio without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 76.56 82.92 97.68 101.58 87.10

Sectra AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 101.58 119.41 90.09 78.92 87.10

MIL:1SECT vs ABT, SYK, MDT: PE Ratio without NRI Comparison

For the Medical Devices subindustry, Sectra AB's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sectra AB PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sectra AB's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Sectra AB's PE Ratio without NRI falls into.


MIL:1SECT
78GF Score
Sectra AB MIL:1SECT
PE Ratio without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sectra AB PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Sectra AB's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=27.38/0.269
=101.78

Sectra AB's Share Price of today is €27.38.
Sectra AB's EPS without NRI for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.27.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.

Frequently Asked Questions Learn more about PE Ratio without NRI →
What does a PE Ratio without NRI of 101.78 mean?
Sectra AB (MIL:1SECT) has a PE Ratio without NRI of 101.78 as of Jun. 27, 2026. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Sectra AB and its competitors. This is 25% above median its historical median of 81.33. Over the past decade, Sectra AB's PE Ratio without NRI has ranged from 34.87 to 146.93. According to the industry distribution chart, Sectra AB ranks #406 out of 448 companies in the Medical Devices & Instruments industry, placing it in the top 90.6%.
Is Sectra AB's PE Ratio without NRI too high?
Sectra AB's current PE Ratio without NRI of 101.78 is 25% above median its 10-year median of 81.33. Over the past 10 years, this metric has ranged from a low of 34.87 to a high of 146.93. The Medical Devices & Instruments industry median PE Ratio without NRI is 23.09. Sectra AB's value of 101.78 is 340.9% above this industry median. Based on the distribution chart, Sectra AB ranks #406 out of 448 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sectra AB has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sectra AB's PE Ratio without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sectra AB ranks #406 out of 448 companies for PE Ratio without NRI. This places Sectra AB in the lower half of its industry. The industry median PE Ratio without NRI is 23.09. Sectra AB's value of 101.78 is 340.9% above this benchmark. Historically, Sectra AB's own PE Ratio without NRI has ranged from 34.87 to 146.93 over the past decade. While the company's 10-year median is 81.33 vs. the industry median of 23.09, Sectra AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PE Ratio without NRI for a Medical Devices & Instruments company?
The median PE Ratio without NRI among Medical Devices & Instruments companies is 23.09, based on 448 companies in the industry. Companies in the top quartile (top 25%) have a PE Ratio without NRI significantly above this median, while those in the bottom quartile fall well below. However, PE Ratio without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sectra AB's current PE Ratio without NRI of 101.78 is 340.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PE Ratio without NRI mean?
A high PE Ratio without NRI can signal that a stock is expensive relative to its fundamentals. P/E without nonrecurring items is the ratio of share price to a company's earnings less one-time charges. View historical data on Sectra AB and its competitors. For the Medical Devices & Instruments industry, the median PE Ratio without NRI is 23.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sectra AB's current PE Ratio without NRI is 101.78, which is 25% above median its own 10-year median of 81.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sectra AB stock overvalued right now?
Based on GuruFocus' analysis, Sectra AB (MIL:1SECT) is currently considered Fairly Valued. The stock's GF Value™ is €28.93, compared to a current price of €27.38 — trading 5.4% below its estimated fair value. The current PE Ratio without NRI is 101.78, which is 25% above median its 10-year median of 81.33 and 340.9% above the Medical Devices & Instruments industry median of 23.09. Sectra AB's overall GF Score™ is 78/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PE Ratio without NRI calculated?
PE Ratio without NRI is calculated from a company's financial statements. For Sectra AB (MIL:1SECT), the current PE Ratio without NRI is 101.78 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sectra AB (MIL:1SECT) Overvalued in 2026?

Based on GuruFocus' analysis, Sectra AB stock appears to be undervalued. The current stock price of €27.38 is trading 5.4% below its estimated GF Value™ of €28.93. GuruFocus considers Sectra AB to be Fairly Valued.

Key valuation signals for MIL:1SECT:

  • PE Ratio without NRI: 101.78 (25% above median its 10-year median of 81.33)
  • GF Value™: €28.93 vs. price of €27.38 (5.4% below fair value)
  • GF Score™: 78/100
  • Industry Position: 340.9% above the Medical Devices & Instruments median (#406 of 448)

No single metric tells the full story. See the MIL:1SECT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sectra AB Business Description

Address Teknikringen 20, Linkoping, SWE, 583 30
Sectra AB develops IT solutions and services for storing, viewing, and working with medical images. The operating business segments are Imaging IT Solutions, Secure Communications, Business Innovation, and Other Operations. It generates maximum revenue from the Imaging IT Solutions segment. The company also offers maintenance in the form of support, system monitoring, and consulting services related to integration, system design, data migration, and business development. Geographically, it derives a majority of its revenue from the United States, followed by Sweden, the United Kingdom, the Netherlands, the Rest of Europe, and the Rest of the world.
78GF Score

Get the complete analysis for MIL:1SECT

PE Ratio without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€27.38
Price
€28.93
GF Value